Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español
Title.gif (16591 bytes)
date.gif (1409 bytes)
NavBar3.gif (2350 bytes)
agenda.gif (421 bytes)
Wednesday, November 1, 2000
8:30 a.m. Welcome and Introductions
Jonathan Fielding, M.D., M.P.H., M.B.A.
Director of Public Health, Los Angeles County

Peter C. Whybrow, M.D.
Chair, UCLA Department of Psychiatry and Behavioral Sciences

Walter Ling, M.D.
Principal Investigator, Pacific Region Clinical Trials Network

9:00 a.m. Putting Drug Abuse Research to Use in Real-Life Settings
Alan I. Leshner, Ph.D., Director, National Institute on Drug Abuse (NIDA)

Questions and Answers

10:30 a.m. Break
11:00 a.m. Bridging the Disconnect Between Practice and Research

Framing the Issues
Real Life Perspectives
Taking Action:  NIDA Clinical Trials Network

12:15 p.m. Lunch
1:15 p.m. Research and Practice Gallery/Dessert and Coffee
1:45 p.m. Workshops
  1. Drugs, the Brain, and Behavior
  2. Effectiveness of Treatment
  3. Innovations in Behavioral Therapy
  4. Innovations in Medications Development for Addiction
  5. Strategies for Working With Cultural Issues/Special Populations
  6. Co-Occurring Disorders
  7. Training Science-Based Treatment Principles
  8. Club Drugs:  Effects and Consequences
3:00 p.m. Break
3:15 p.m. Workshops
  1. Buprenorphine/Naloxone for Opiate Detox and Treatment
  2. Motivational Enhancement
  3. Motivational Incentives
  4. Medical Consequences of Drug Use
  5. Understanding Methadone and LAAM
  6. Adolescents and Drug Abuse:  Treatment Perspectives
  7. Gender Issues in Treatment
  8. Methamphetamine Treatment
4:30 p.m. Adjourn
Thursday, November 2, 2000
8:30 a.m. Welcome
Patrick Ogawa
Nancy Kaufmann
Douglas Anglin

Forging Partnerships to Enhance Drug Treatment:  Focus on Los Angeles

The Burden of Disease in Los Angeles
Paul Simon, M.D., M.P.H., Los Angeles Public Health

The Drug Evaluation Network Survey:  DENS Project
Thomas McLellan, Ph.D., Delaware Valley CTN

Los Angeles County Evaluation System (LACES)
Richard Rawson, Ph.D., Pacific Region CTN
Douglas Anglin, Ph.D., Pacific Region CTN

10:15 a.m. Break
10:45 a.m. Workshops

Drugs, the Brain, and Behavior
Co-Occurring Disorders
Club Drugs:  Effects and Consequences
Adolescents and Drug Abuse
Gender Issues in Treatment
Methamphetamine Treatment

Working Group—Forging Partnerships:  Next Steps for Los Angeles

12 noon Lunch
1:00 p.m. Forging Partnerships:  Next Steps for Los Angeles
Presentation of Morning Working Group's Work
Panel Discussion
Questions and Answers
2:30 p.m. Adjourn


NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version



National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Monday, January 22, 2001. The U.S. government's official web portal